The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Merck Serono Ventures Fund

New Merck Serono Biotechnology Ventures Fund

Merck KGaA, the Darmstadt-based company (not part of Merck & Co. Inc. of the U.S.),  is starting a biotechnology venture capital fund that will invest €40 million ($55 million) in emerging biotech companies during the next five years, with a focus on the core therapeutic areas of Neurodegenerative Diseases, Oncology, Autoimmune & Inflammatory Diseases, Endocrinology and Fertility, as well as enabling tool and discovery technologies.  Companies wishing to submit proposals or receive additional information can contact Merck Serono Ventures via their website.

Bookmark and Share


Get every new post delivered to your Inbox.

Join 128 other followers